Sentinel lymph node mapping in early breast cancer - Our experience

被引:5
作者
Challa V.R. [1 ]
Seenu V. [1 ]
Srivastava A. [1 ]
Kumar R. [2 ]
Dhar A. [1 ]
Chumber S. [1 ]
Parshad R. [1 ]
Misra M.C. [1 ]
机构
[1] Department of Surgery, All India Institute of Medical Sciences, New Delhi
[2] Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi
关键词
Axillary lymph node dissection; Axillary node sampling; Early breast cancer; Immuohistochemistry; Lymphatic mapping; Sentinel lymph node biopsy;
D O I
10.1007/s13193-010-0012-z
中图分类号
学科分类号
摘要
Background: The axillary lymph node status is the most important determinant of prognosis in patients with breast cancer. Sentinel lymph node (SLN) biopsy is a safe alternative for axillary clearance with an equal efficacy limiting the morbidity caused by axillary clearance. Patient and methods: From May 1996 till September 2009, 523 clinically node negative, early breast cancer patients attending our clinic at All India Institute of Medical Sciences were included in the study. They underwent sentinel lymph node biopsy by either combined technique or blue dye alone. All patients irrespective of the axillary status underwent axillary lymph node dissection (ALND). Results: Of 523 patients, 267 underwent combined technique of sentinel node mapping and 256 underwent blue dye technique alone. The identification rate of sentinel lymph node was 94.3% (253/267) for combined technique and 87.8% (225/256) for blue dye alone. Of 523 patients SLN was identified in 478 patients. The identification rate was 91.3%. The sensitivity = 91.5% (141/154), false negative = 8.4% (13/154), negative predictive value = 96.14% (324/337), and accuracy being 97.2% (465/478). Conclusion: Sentinel node mapping is a simple and safe technique of identifying the axillary node involvement. Sentinel lymph node biopsy is associated with less arm oedema and shoulder morbidity compared to ALND. However, the results of long term effects of sentinel node approach on tumor recurrence or patient survival are awaited. © 2010 Indian Association of Surgical Oncology.
引用
收藏
页码:52 / 58
页数:6
相关论文
共 26 条
[1]  
Nemoto T., Vana J., Bedwani R.N., Baker H.W., McGregor F.H., Murphy G.P., Management and survival of female breastcancer: results of a national survey by the American College of Surgeons, Cancer, 45, pp. 2917-2924, (1980)
[2]  
Carter C.L., Allen C., Henson D.E., Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases, Cancer, 63, pp. 181-187, (1989)
[3]  
Orr R.K., The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis, Ann Surg Oncol, 6, pp. 109-116, (1999)
[4]  
Sanghani M., Balk E.M., Cady B., Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and metaanalysis, Cancer, 115, 8, pp. 1613-1620, (2009)
[5]  
Hughes R.J., Jones C., Holland P.A., Et al., Prediction of axillary lymph node metastasis by size and grade of tumor - an aid for the discussion of axillary surgery in patients with operable disease, Eur J Cancer, 5, (2007)
[6]  
Chetty U., Jack W., Prescott R.J., Et al., A management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial, Br J Surg, 87, pp. 163-169, (2000)
[7]  
Forrest A.P.M., Everington D., McDonald C.C., Et al., The Edinburgh randomized trial of axillary sampling or clearance after mastectomy, Br J Surg, 82, pp. 1504-1508, (1995)
[8]  
Axelsson C.K., Mouridsen H.T., Zedeler K., Axillary dissection of level I and II lymph nodes is important in breast cancer classification, Eur J Cancer, 28 A, pp. 1415-1418, (1992)
[9]  
Cabanas R.M., An approach for the treatment of penile carcinoma, Cancer, 39, pp. 456-466, (1997)
[10]  
Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L., Lymphatic mapping and sentinel lymphadenec-tomy for breast cancer, Ann Surg, 220, pp. 391-401, (1994)